Association of MiR-146a Expression and Type 2 Diabetes Mellitus: A Meta-Analysis
- PMID: 29682487
- PMCID: PMC5898639
- DOI: 10.22088/acadpub.BUMS.6.3.156
Association of MiR-146a Expression and Type 2 Diabetes Mellitus: A Meta-Analysis
Abstract
Although deregulation of miR-146a has been reported in type 2 diabetes repeatedly, the direction of deregulation events (up or down) remained to be inconsistent in literatures. Therefore, in this study we performed a meta-analysis on the possible association between miR-146a expression levels and type 2 diabetes. A systematic literature searching of PubMed, ISI Web of Science and Google Scholar was performed up to the end of September 2016. Finally, a total of 12 studies including 344 diabetic patients and 316 controls were selected for meta-analysis. All statistical analysis was performed using the metafor package with R software. Moreover, publication bias was assessed by Egger's and sensitivity analysis was applied on the meta-analysis. The results are presented as log10 odds ratios (logORs), 95% confidence intervals (CI) with relevant P values. The results revealed that miR-146a was downregulated in type 2 diabetes cases compared with normal subjects (P=0.01, logOR:-4.76, 95% CI:-8.41, -1.11). Furthermore, sub-group analysis showed that the association between miR-146a expression levels and type 2 diabetes in whole blood (P<0.001) and PBMCs (P<0.001) samples were significant. However, this association was not significant in the serum (P=0.67) and plasma (P=0.90) samples. Our finding suggests that miR-146a downregulation could be associated with type 2 diabetes susceptibility. Further investigations with larger sample size are required to evaluate this association in the type 2 diabetes pathogenesis.
Keywords: Type 2 diabetes; meta-analysis; microRNA-146a.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Ahlqvist E, van Zuydam NR, Groop LC, et al. The genetics of diabetic complications. Nat Rev Nephrol. 2015;11:277–87. - PubMed
-
- Khodabandehloo H, Gorgani-Firuzjaee S, Panahi G, et al. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Transl Res. 2016;167:228–56. - PubMed
-
- Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49. - PubMed
-
- McClelland AD, Kantharidis P. microRNA in the development of diabetic complications. Clin Sci (Lond) 2014;126:95–110. - PubMed
-
- Raffort J, Hinault C, Dumortier O, et al. Circulating microRNAs and diabetes: potential applications in medical practice. Diabetologia. 2015;58:1978–92. - PubMed
Publication types
LinkOut - more resources
Full Text Sources